Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

Certain changes in the SHBG gene may increase the risk of PCOS in Iraqi women.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

The protein STAT3 slows down cell growth by blocking the FST gene, which affects hair development in sheep.

Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Certain genetic variations are linked to hair loss in Mexican men.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Mutations in the AR gene cause hair thinning and loss.

A new gene, JMJD1C, may affect testosterone levels in men.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

There is no significant link between alopecia areata and the PON1 enzyme polymorphisms studied.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.